{"grounding": "Club cell secretory protein (CCSP), also known as secretoglobin 1A1 (gene name SCGB1A1), is one of the most abundant proteins in the lung, primarily produced by club cells of the distal airway epithelium. At baseline, CCSP is found in large concentrations in lung fluid specimens and can also be detected in the blood and urine. Obstructive lung diseases are generally associated with reduced CCSP levels, thought to be due to decreased CCSP production or club cell depletion. Conversely, several restrictive lung diseases have been found to have increased CCSP levels both in the lung and in the circulation, likely related to club cell dysregulation as well as increasedlung permeability. Recent studies demonstrate multiple mechanisms by which CCSP dampens acute and chronic lung inflammation. Given these anti-inflammatory effects, CCSP represents a novel potential therapeutic modality in lung disease.", "generated_text": "Club cell secretory protein (CCSP), also known as CC10, uteroglobin, or secretoglobin 1A1 (SCGB1A1), is a pivotal component in lung biology, with emerging roles in the pathophysiology of various lung diseases. This review synthesizes recent advances in understanding CCSP's function as a biomarker and its therapeutic potential. CCSP is primarily secreted by club cells in the bronchiolar epithelium and is involved in modulating inflammation, immune responses, and tissue repair. Altered levels of CCSP have been associated with chronic obstructive pulmonary disease, asthma, and lung cancer, highlighting its diagnostic and prognostic value. Furthermore, therapeutic strategies targeting CCSP pathways are being explored, offering promising avenues for intervention. This paper discusses the molecular mechanisms underlying CCSP's protective effects and evaluates its potential as a therapeutic target in lung disease management.", "label": 1}